As a common type of intracranial neoplasm, the unique characteristic signs of pituitary adenomas are often the primary reason patients seek medical care. Data released by the Chinese Pituitary Adenoma Cooperative Group in 2023 shows the annual incidence of pituitary adenomas in China stands at 7–10 per 100,000 population, among which functional pituitary adenomas account for approximately 75%. These tumors trigger a series of pathognomonic signs via excessive hormone secretion or mass compression of adjacent anatomical structures. Early recognition of these manifestations is critical for timely diagnosis and intervention.

Typical Signs of Growth Hormone-Secreting Pituitary Adenomas

Excess growth hormone induces acromegaly in adults and gigantism in children, presenting highly specific clinical signs. Adult patients develop acromegalic features: gradual enlargement of hands and feet, coarse facial contours and prominent supraorbital ridges. Patients often report tighter rings and larger shoe sizes; these subtle changes are easily overlooked in the early stage. Onset during childhood causes gigantism, with height exceeding the 97th percentile of age-matched peers.

Imaging studies identify sellar masses in 96.5% of patients with GH adenomas. Serum IGF-1 measurement serves as a core screening tool with a sensitivity of 94.8%. Failure to suppress GH below 1 μg/L during the oral glucose tolerance test is the gold standard for definitive diagnosis. Early intervention achieves a 68.3% reversal rate of metabolic derangements.

Characteristic Signs of ACTH-Secreting Pituitary Adenomas

Excess ACTH secretion leads to Cushing’s syndrome with highly distinctive physical signs. Central obesity is the hallmark feature, with abnormal fat deposition in the face (moon facies) and dorsocervical region (buffalo hump). Skin thinning results in purplish striae, most commonly distributed over the abdomen and medial thighs. Plethoric facies, acne and hirsutism are also prevalent manifestations.

Laboratory testing reveals loss of normal diurnal cortisol rhythm; midnight cortisol levels deliver a diagnostic specificity of 92.4%. The low-dose dexamethasone suppression test is essential for differential diagnosis. Chronic hypercortisolism induces metabolic complications including hypertension and impaired glucose tolerance, and prompt treatment significantly improves long-term prognosis.

Endocrine-Related Signs of Pituitary Adenomas

Gonadal Dysfunction

Female patients with prolactinomas develop amenorrhea-galactorrhea syndrome, while men present with decreased libido and erectile dysfunction. Tumor compression-induced gonadotropin deficiency leads to abnormal secondary sexual development, testicular atrophy or gynecomastia.

Thyroid Axis Abnormalities

TSH-secreting adenomas are rare yet produce obvious hyperthyroid manifestations such as palpitations, hyperhidrosis and unintentional weight loss. Unlike primary hyperthyroidism, patients with TSH adenomas show blunted responses to the TRH stimulation test, and imaging confirms a sellar mass lesion.

Compressive Signs Secondary to Pituitary Mass Effect

Visual Pathway Compression

Suprasellar tumor extension compresses the optic chiasm and causes pathognomonic bitemporal hemianopia. Patients initially notice peripheral visual field loss, which progresses to tunnel vision in advanced stages. The severity of visual impairment correlates with tumor size; visual deficits occur in up to 83.7% of patients with giant macroadenomas.

Cranial Nerve Involvement

Lateral tumor invasion compresses cranial nerves III, IV and VI, resulting in ptosis and diplopia. Trigeminal nerve involvement triggers facial paresthesia. Cavernous sinus infiltration may cause pupillary abnormalities and restricted extraocular movements.

Unique Signs of Special Pituitary Adenoma Subtypes

Silent ACTH-Secreting Adenomas

These lesions do not overproduce hormones, yet compressive symptoms emerge once they reach large volumes. Headache is the most frequent chief complaint with an incidence of 71.5%, typically caused by traction on the sellar diaphragm.

Plurihormonal Adenomas

Tumors secreting multiple hormones generate complex overlapping clinical signs. Patients may simultaneously exhibit features of acromegaly and Cushing’s syndrome, requiring combined hormonal testing and imaging for definitive diagnosis.

Natural Evolution of Clinical Signs

The progression of pituitary adenoma manifestations follows predictable patterns. Patients with functional adenomas generally present early due to symptomatic hormonal disturbances, with an average diagnostic delay of 11.8 months. Non-functional adenomas are usually diagnosed only after compressive signs develop or incidental detection, often at a larger tumor size.

The rate of sign progression depends on tumor biological behavior. Invasive pituitary adenomas grow rapidly with an average doubling time of 6.2 months and rapid deterioration of clinical manifestations. Benign slow-growing lesions produce subtle changes evolving over years.